B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.
about
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer PanelThe mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.Functional roles of HIV-1 Tat protein in the nucleus.Human genomics projects and precision medicine.Predispositions to Lymphoma: A Practical Review for Genetic Counselors.Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers.Rubinstein-Taybi syndrome - a window into follicular lymphoma biology.Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells.Prolyl 4-Hydroxylase 2 Promotes B-cell Lymphoma Progression via Hydroxylation of Carabin.Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB.Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.The Classification of Lymphomas: Updating the WHO ClassificationTRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation
P2860
Q35691157-5B08806F-7A7D-4D81-A7CE-1C8C5D3A9863Q36001708-8BE5365D-0AC8-4558-94A3-0D3FF4807302Q37221579-437EB958-918E-48E5-AC9B-A589E32CA5E3Q37324841-E85E27BE-3136-4C98-A9E5-90C7F9A23598Q37725561-4BFF7344-9466-499E-A3B7-D7F127A59746Q38617624-C1C6A8BF-8F83-408F-BE82-CD01B6A95918Q38626087-030D0ADC-D1D9-4218-8650-621C2CC7FAF3Q38855962-2F659CDF-0200-496D-82A6-601D1126AF0BQ39170884-799D7BD0-DEEA-485C-86D5-41DC5D94CAEFQ40387247-3AF24EEF-5D2F-4C30-B444-6E0C5E34B00EQ46225953-9552FDDF-E30C-4470-AC32-7A706E63D764Q46238878-E716CF47-654F-4448-9363-23F52D690F0AQ50044422-523FAB39-66A6-47DF-B271-7BE57FC951F3Q54858561-B013AED9-4C65-4AD5-8D9C-8EF3A1664070Q55455226-46F00E84-00FA-4A72-A96A-236F137CF5B3Q57279267-B62EEFDA-2D75-4748-B366-C3ACD1549E58Q57492396-0E1C6C3B-96B2-48DA-B4E1-4DEBC4E2CEE7
P2860
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.
@en
type
label
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.
@en
prefLabel
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.
@en
P2860
P50
P1433
P1476
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.
@en
P2093
Ana Batlle-López
Cristina Pérez
P2860
P304
P356
10.3324/HAEMATOL.2013.096248
P577
2014-02-01T00:00:00Z